Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)
CNY 81.2
(-2.84%)
CNY 81.2
(-2.84%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.37 Billion CNY | 27.14% |
| 2022 | 3.44 Billion CNY | 9.96% |
| 2021 | 3.13 Billion CNY | 4.79% |
| 2020 | 2.98 Billion CNY | 124.86% |
| 2019 | 1.32 Billion CNY | 254.25% |
| 2018 | 374.99 Million CNY | -26.27% |
| 2017 | 508.63 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 5.43 Billion CNY | 9.66% |
| 2024 Q2 | 4.95 Billion CNY | 5.4% |
| 2024 Q1 | 4.7 Billion CNY | 7.4% |
| 2023 Q4 | 4.37 Billion CNY | 10.1% |
| 2023 FY | 4.37 Billion CNY | 27.14% |
| 2023 Q3 | 3.97 Billion CNY | 7.51% |
| 2023 Q1 | 3.45 Billion CNY | 0.44% |
| 2023 Q2 | 3.69 Billion CNY | 6.94% |
| 2022 Q2 | 3.15 Billion CNY | 2.59% |
| 2022 Q1 | 3.07 Billion CNY | -1.89% |
| 2022 Q4 | 3.44 Billion CNY | 7.24% |
| 2022 FY | 3.44 Billion CNY | 9.96% |
| 2022 Q3 | 3.2 Billion CNY | 1.88% |
| 2021 Q2 | 2.95 Billion CNY | -0.09% |
| 2021 Q3 | 3.17 Billion CNY | 7.43% |
| 2021 FY | 3.13 Billion CNY | 4.79% |
| 2021 Q1 | 2.95 Billion CNY | -1.07% |
| 2021 Q4 | 3.13 Billion CNY | -1.3% |
| 2020 Q1 | 1.17 Billion CNY | -11.88% |
| 2020 FY | 2.98 Billion CNY | 124.86% |
| 2020 Q4 | 2.98 Billion CNY | 175.85% |
| 2020 Q3 | 1.08 Billion CNY | -3.98% |
| 2020 Q2 | 1.12 Billion CNY | -3.66% |
| 2019 FY | 1.32 Billion CNY | 254.25% |
| 2019 Q4 | 1.32 Billion CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 374.99 Million CNY | -26.27% |
| 2017 FY | 508.63 Million CNY | 0.0% |